Clinical Trials Update: Feb. 20, 2007
Non-Small Cell Lung Cancer Bipolar Disorders Constipation
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Non-Small Cell Lung Cancer
This clinical study will evaluate if an investigational drug is effective in treating non-small cell lung cancer (NSCLC). To qualify for the study, you must be age 18 or older, diagnosed with NSCLC, and have had at least one session of chemotherapy but not more than two.
The research site is in Wichita, KS.
This study will evaluate the safety and efficacy of sustained-release quetiapine fumarate (Seroquel) for eight weeks to treat acute bipolar depression. Participants must be 18-65, have a documented diagnosis of bipolar disorder, and have outpatient status at enrollment. Other criteria apply.
The research site is in West Palm Beach, Fla.
This study will evaluate if lubiprostone is safe and effective for use in children. Participants must be 17 or younger, weigh at least 26 1/2 pounds (12 kg), be capable of swallowing capsules, and be diagnosed with constipation.
The research site is in Little Rock, Ark.
Copyright 2007 Thomson CenterWatch. All rights reserved.